Company: WHWK
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001628280-25-015269
Chunk: 285

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 5
Chunk 285
---
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities. 

Market Information

Our common stock trades on the Nasdaq Capital Market, commencing on August 27, 2021.  Prior to March 19, 2025, our common stock traded under the symbol “AADI” and currently trades under the symbol "WHWK". 

Stockholders

As of March 24, 2025, there were 81 stockholders of record of our common stock.   

Dividends

We have never declared nor paid any cash dividends to stockholders. We do not intend to pay cash dividends on our common stock for the foreseeable future, and currently intend to retain any future earnings to fund our operations and the development and growth of our business. The declaration of any future cash dividends, if any, would be at the discretion of our board of directors (subject to limitations imposed under applicable Delaware law) and would depend on our earnings, if any, our capital requirements and financial position, our general economic conditions and other pertinent conditions.

Unregistered Sales of Equity Securities and Use of Proceeds

There have been no unregistered sales of securities other than previously disclosed by us on Form 10-Q or Form 8-K.

Issuer Purchases of Equity Securities

There were no repurchases of shares of common stock made during the year ended December 31, 2024.